2-Ethyl-3-hydroxy-6-methylpyridine - CAS 2364-75-2
Catalog: |
BB018129 |
Product Name: |
2-Ethyl-3-hydroxy-6-methylpyridine |
CAS: |
2364-75-2 |
Synonyms: |
2-ethyl-6-methyl-3-pyridinol; 2-ethyl-6-methylpyridin-3-ol |
IUPAC Name: | 2-ethyl-6-methylpyridin-3-ol |
Description: | An antidepressant agent. |
Molecular Weight: | 137.18 |
Molecular Formula: | C8H11NO |
Canonical SMILES: | CCC1=C(C=CC(=N1)C)O |
InChI: | InChI=1S/C8H11NO/c1-3-7-8(10)5-4-6(2)9-7/h4-5,10H,3H2,1-2H3 |
InChI Key: | JPGDYIGSCHWQCC-UHFFFAOYSA-N |
Boiling Point: | 280.6 °C at 760 mmHg |
Density: | 1.053 g/cm3 |
MDL: | MFCD00462409 |
LogP: | 1.65800 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
RU-206168-U1 | Atraumatic dressing for the treatment of wounds in animals | 20210215 |
RU-2752065-C1 | Method for treatment of patients with chronic heart failure and chronic brain ischemia | 20210202 |
RU-2747408-C1 | Method for complex treatment of hemodynamic disorders of bulbar conjunctiva of patients with covid-19 associated pneumonia | 20210123 |
RU-2750964-C1 | Method for correction of bacterial purulent meningitis with bis (2-ethyl-6-methyl-3-hydroxypyridinium)2,6-dichlorophenyl (amino)phenylethanoate under experimental conditions | 20201230 |
RU-2750418-C1 | Drug with antihypoxic, antiamnestic and neuroprotective activity | 20201120 |
PMID | Publication Date | Title | Journal |
22935506 | 20120901 | 2-Ethyl-6-methylpyridin-3-ol and its salt bis(2-ethyl-3-hydroxy-6-methylpyridinium) succinate | Acta crystallographica. Section C, Crystal structure communications |
23101251 | 20120901 | [Preservation of leukocytes at moderately low temperature] | Fiziologiia cheloveka |
22994106 | 20120701 | [The influence of water soluble antioxidant agent (mexidol) on optic nerve and blood flow velocity in ocular and orbital arteries in patients with primary open-angle glaucoma] | Vestnik oftalmologii |
22223285 | 20120101 | Two succinic acid derivatives of 2-ethyl-6-methylpyridin-3-ol | Acta crystallographica. Section C, Crystal structure communications |
22442954 | 20120101 | [Electrophysiological study of the mechanism of mexidol action] | Eksperimental'naia i klinicheskaia farmakologiia |
Complexity: | 105 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 137.084063974 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 137.084063974 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 33.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Pyridines
-
[104496-91-5]
2-(Pyridin-2-ylthio)acetohydrazide
-
[76167-49-2]
2-(Pyridin-3-yloxy)aniline
-
[2122800-15-9]
3-(Phenyl-4-D)-N,N-dimethyl-3-(2-pyridyl)-1-propanamine
-
[144584-32-7]
3-Bromo-2,4-dichloropyridine
-
[2241983-13-9]
5-[(8S,9S,13S,14S)-3-Methoxy-13-methyl-7,8,9,11,12,13,14,15-octahydro-6H-cyclopenta[a]phenanthren-17-yl]pyridine-2-D
-
[1011398-65-4]
6-(4-(Difluoromethoxy)phenyl)-3-methylisoxazolo[5,4-b]pyridine-4-carboxylic acid
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS